Email This Article
Headlines & Perspectives
United Therapeutics Execs Profit While Stock Slides
By
Adam Feuerstein
12/03/08 - 12:15 PM EST
United Therapeutics changed the terms of stock option grants to certain executives, allowing them to reap profits despite a steep plunge in the company's stock price.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,305.01 | 1,091.81 | 2,139.10 | 32.34 |
Oil *
75.96
|
|
DOWN
159.39
|
DOWN
18.82
|
DOWN
36.95
|
DOWN
0.45
|
10 Yr
3.23%
SPDR Gold
114.74
|
|
-1.52%
|
-1.69%
|
-1.70%
|
-1.37%
|
Data delayed 20 minutes |


Connect with TheStreet